Pricing Log in Create free account

AN2 Therapeutics, Inc. (ANTX) vs Anavex Life Sciences Corp. (AVXL)

AN2 Therapeutics, Inc. and Anavex Life Sciences Corp. are both Biotechnology companies. AN2 Therapeutics, Inc. and Anavex Life Sciences Corp. are of similar size ($137.2M and $135.9M). Across the 8 metrics below, Anavex Life Sciences Corp. leads on 5 and AN2 Therapeutics, Inc. on 3.

Valuation

Metric ANTX AVXL Biotechnology median
P/E n/m n/m 8.42
P/S n/m n/m 10.01
P/B 2.12 1.22 2.21
Price to free cash flow n/m n/m 21.01
EV/EBITDA n/m n/m 0.61
EV/Sales n/m n/m 9.41
Earnings yield (29.81%) (10.14%) (31.85%)
Free cash flow yield (19.09%) (21.35%) (24.58%)

Profitability

Metric ANTX AVXL Biotechnology median
Gross margin 0.00% — 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (50.12%) (12.80%) (56.36%)
Return on assets (46.06%) (11.70%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ANTX AVXL Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 32.56% (3.85%) 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ANTX AVXL Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 14.32 15.62 4.72
Net debt to EBITDA 1.48 2.00 0.96

Dividend

Metric ANTX AVXL Biotechnology median
Dividend yield — — 0.08%
Payout ratio — — —

Size

Metric ANTX AVXL Biotechnology median
Market cap 135.85m 137.19m 132.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack